Mario Eandi

1.4k total citations
55 papers, 879 citations indexed

About

Mario Eandi is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mario Eandi has authored 55 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Mario Eandi's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Analytical Methods in Pharmaceuticals (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Mario Eandi is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Analytical Methods in Pharmaceuticals (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Mario Eandi collaborates with scholars based in Italy, Slovakia and Chile. Mario Eandi's co-authors include Gian Paolo Zara, Roberto Canaparo, Elisabetta Muntoni, Loredana Serpe, Maria Rosa Gasco, Carlo Della Pepa, I Viano, Lorenzo Pradelli, Roberta Cavalli and Elena Ugazio and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pain and Thrombosis and Haemostasis.

In The Last Decade

Mario Eandi

47 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Eandi Italy 18 199 134 131 124 97 55 879
Keith E. Anderson Canada 9 152 0.8× 201 1.5× 98 0.7× 175 1.4× 78 0.8× 18 807
Armand Frydman France 23 279 1.4× 110 0.8× 196 1.5× 290 2.3× 99 1.0× 42 1.7k
Frits Moolenaar Netherlands 21 425 2.1× 172 1.3× 194 1.5× 121 1.0× 108 1.1× 68 1.3k
Tawfiq Arafat Jordan 18 226 1.1× 106 0.8× 79 0.6× 131 1.1× 33 0.3× 97 1.1k
Lawrence S. Olanoff United States 17 123 0.6× 162 1.2× 91 0.7× 141 1.1× 57 0.6× 27 823
Seigo Iwakawa Japan 21 529 2.7× 149 1.1× 173 1.3× 163 1.3× 114 1.2× 94 1.3k
Selma Şahin Türkiye 19 203 1.0× 362 2.7× 126 1.0× 108 0.9× 193 2.0× 86 1.2k
J.J. Vallner United States 15 399 2.0× 76 0.6× 159 1.2× 139 1.1× 87 0.9× 46 941
D.G. Perrier United States 21 331 1.7× 208 1.6× 193 1.5× 223 1.8× 211 2.2× 45 1.3k
Ahmad Y. Abuhelwa Australia 17 240 1.2× 194 1.4× 250 1.9× 92 0.7× 46 0.5× 65 1.1k

Countries citing papers authored by Mario Eandi

Since Specialization
Citations

This map shows the geographic impact of Mario Eandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Eandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Eandi more than expected).

Fields of papers citing papers by Mario Eandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Eandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Eandi. The network helps show where Mario Eandi may publish in the future.

Co-authorship network of co-authors of Mario Eandi

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Eandi. A scholar is included among the top collaborators of Mario Eandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Eandi. Mario Eandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eandi, Mario. (2023). The Importance of the Pharmacoeconomic Analyses in Drug Negotiation. A Farewell Editorial. SHILAP Revista de lepidopterología. 24(1).
2.
Pradelli, Lorenzo, Mario Eandi, Massimiliano Povero, et al.. (2013). Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: A discrete event simulation model. Clinical Nutrition. 33(5). 785–792. 23 indexed citations
3.
Pradelli, Lorenzo, et al.. (2012). EFFECTIVENESS AND COST-EFFECTIVENESS OF SUPPLEMENTAL GLUTAMINE DIPEPTIDE IN TOTAL PARENTERAL NUTRITION THERAPY FOR CRITICALLY ILL PATIENTS: A DISCRETE EVENT SIMULATION MODEL BASED ON ITALIAN DATA. International Journal of Technology Assessment in Health Care. 28(1). 22–28. 15 indexed citations
4.
Eandi, Mario. (2009). Hospital Management of Complicated Intra-abdominal infections: Pharmacoeconomic Evaluation. Journal of Chemotherapy. 21(sup1). 44–55. 1 indexed citations
5.
Pradelli, Lorenzo & Mario Eandi. (2008). [Palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in Italy: pharmacologic, clinical and economic aspects].. PubMed. 94(2). suppl 26–32. 2 indexed citations
6.
Serpe, Loredana, Roberto Canaparo, Elisabetta Muntoni, et al.. (2006). Intracellular Accumulation and Cytotoxicity of Doxorubicin with Different Pharmaceutical Formulations in Human Cancer Cell Lines. Journal of Nanoscience and Nanotechnology. 6(9). 3062–3069. 30 indexed citations
7.
Serpe, Loredana, Maria Graziella Catalano, Roberta Cavalli, et al.. (2004). Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. European Journal of Pharmaceutics and Biopharmaceutics. 58(3). 673–680. 138 indexed citations
8.
Serpe, Loredana, Stefano Laurora, Stefania Pizzimenti, et al.. (2004). Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells. Anti-Cancer Drugs. 15(5). 525–536. 21 indexed citations
9.
Eandi, Mario. (2004). Costo-efficacia dell’amfotericina B liposomiale nella terapia dell’aspergillosi invasiva. SHILAP Revista de lepidopterología. 5(1). 47–61. 1 indexed citations
10.
Eandi, Mario, et al.. (2003). Recombinant Escherichia coli for the biomonitoring of benzene and its derivatives in the air. Ecotoxicology and Environmental Safety. 57(2). 118–122. 15 indexed citations
11.
Muntoni, Elisabetta, Roberto Canaparo, Loredana Serpe, et al.. (2003). Determination of disodium clodronate in human plasma and urine using gas-chromatography–nitrogen-phosphorous detections: validation and application in pharmacokinetic study. Journal of Chromatography B. 799(1). 133–139. 13 indexed citations
12.
Casale, Federico, Roberto Canaparo, Elisabetta Muntoni, et al.. (2002). Simultaneous HPLC determination of 5‐fluorouracil and its metabolites in plasma of cancer patients. Biomedical Chromatography. 16(7). 446–452. 25 indexed citations
13.
Eandi, Mario, G.P. Zara, & Carlo Della Pepa. (2000). Application of pharmacoeconomics to the use of antibiotics. Clinical Microbiology and Infection. 6. 90–92. 3 indexed citations
14.
Canaparo, Roberto, Federico Casale, Elisabetta Muntoni, et al.. (2000). Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapy. British Journal of Clinical Pharmacology. 50(2). 146–153. 24 indexed citations
15.
Cooke, Jonathan, et al.. (1997). Pharmacoeconomic aspects of antibacterial treatment with cefotaxime.. PubMed. 9 Suppl 2. 34–45. 2 indexed citations
16.
Eandi, Mario. (1992). Kinetics of effects. Pharmacological Research. 26. 118–118. 1 indexed citations
17.
Eandi, Mario, et al.. (1991). [Piroxicam in analgesia].. PubMed. 136(2). 107–35. 3 indexed citations
18.
Arduino, Carlo & Mario Eandi. (1989). Kinetics of thyroxine epicutaneous absorption. Pharmacological Research. 21(1). 109–110. 4 indexed citations
19.
Magni, Guido, et al.. (1987). [3H]Imipramine Binding Sites are Decreased in Platelets of Chronic Pain Patients. Clinical Neuropharmacology. 10(2). 175–177. 6 indexed citations
20.
Magni, Guido, et al.. (1987). Modifications of [3H]imipramine binding sites in platelets of chronic pain patients treated with mianserin. Pain. 30(3). 311–320. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith E. Anderson Breakdown of academic impact, for papers by Armand Frydman Breakdown of academic impact, for papers by Frits Moolenaar Breakdown of academic impact, for papers by Tawfiq Arafat Breakdown of academic impact, for papers by Lawrence S. Olanoff Breakdown of academic impact, for papers by Seigo Iwakawa Breakdown of academic impact, for papers by Selma Şahin Breakdown of academic impact, for papers by J.J. Vallner Breakdown of academic impact, for papers by D.G. Perrier Breakdown of academic impact, for papers by Ahmad Y. Abuhelwa
Rankless by CCL
2026